FFA
FLGT icon

First Foundation Advisors’s Fulgent Genetics FLGT Stock Holding History

First Foundation Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,728
Closed -$295K – 415
2022
Q1 		$295K Hold
4,728
– – 0.01% 338
2021
Q4 		$476K Hold
4,728
– – 0.02% 270
2021
Q3 		$425K Buy
4,728
+182
+4% +$16.5K 0.02% 298
2021
Q2 		$419K Buy
4,546
+198
+5% +$15.8K 0.02% 311
2021
Q1 		$420K Buy
+4,348
New +$449K 0.02% 290

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Foundation Advisors's FLGT Position: Q2 2022 in Review

First Foundation Advisors sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 4,728 shares — an estimated $295K sold.

First Foundation Advisors first reported a position in FLGT in Q1 2021 and held it in 5 quarters. The position peaked at $476K in Q4 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • First Foundation Advisors reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • First Foundation Advisors sold 4,728 Fulgent Genetics shares in Q2 2022, an estimated $295K.
  • First Foundation Advisors first reported a position in Fulgent Genetics in Q1 2021 and held it in 5 quarters.
  • First Foundation Advisors's Fulgent Genetics position peaked at $476K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on First Foundation Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.